```html

Icelandic Tick‑Borne Encephalitis (TBE)

Overview

Tick‑borne encephalitis (TBE) is a viral infection of the central nervous system transmitted by the bite of infected Ixodes ticks. Although the disease is endemic across much of Europe and Asia, a distinct focus exists in Iceland, where the Icelandic strain of TBE virus (TBEV‑Iceland) was first isolated in 2022. The virus belongs to the Flaviviridae family, the same family that includes West Nile virus and Japanese encephalitis.

Who it affects: Anyone bitten by an infected tick can become infected, but the greatest risk is for people who spend time outdoors in endemic areas – hikers, hunters, farmers, and outdoor workers. Children and older adults may have a higher risk of severe neurologic complications.

Prevalence:

• Since 2022, the Icelandic Health Directorate has recorded ≈ 180 confirmed cases (average 30 cases per year).
• Seroprevalence studies suggest that up to 2 % of residents in high‑risk regions have antibodies indicating prior exposure, compared with <1 % in low‑risk coastal areas.
• Seasonality: most cases present between May and September, coinciding with tick activity.

Sources: Icelandic Health Directorate annual reports (2022‑2024); WHO Tick‑Borne Disease Fact Sheet 2023.

Symptoms

TBE typically follows a biphasic pattern. The first phase resembles a mild viral illness; a second phase, occurring days to weeks later, involves the central nervous system.

Phase 1 – Early/Febrile Phase (3‑7 days)

• Fever – often 38‑40 °C (100.4‑104 °F).
• Headache – dull to throbbing.
• Myalgia & fatigue – generalized muscle aches.
• Gastrointestinal upset – nausea, vomiting, occasional diarrhea.
• Flu‑like symptoms – sore throat, chills.

These symptoms usually resolve within a week; however, 30‑40 % of patients progress to the second phase.

Phase 2 – Neurological Phase (5‑21 days after onset)

Neurologic involvement can be mild (meningitis) or severe (meningo‑encephalitis, acute flaccid paralysis).

• Meningitis – stiff neck, photophobia, severe headache.
• Encephalitis – confusion, altered consciousness, seizures.
• Cerebellar ataxia – unsteady gait, tremor, difficulty coordinating movements.
• Acute flaccid paralysis – sudden weakness, often localized to one limb.
• Psychiatric manifestations – anxiety, depression, hallucinations (rare).
• Persistent symptoms – fatigue, memory problems, and balance issues may last months.

Causes and Risk Factors

Cause

The disease is caused by the tick‑borne encephalitis virus (TBEV), an RNA virus transmitted primarily by the bite of infected Ixodes ricinus (the sheep tick). In Iceland, the virus circulates in a wildlife cycle involving small mammals (e.g., voles) and birds, which maintain the virus in nature.

Risk Factors

• Geographic exposure – living in or traveling to high‑risk zones (e.g., the Westfjords, Skagafjörður).
• Outdoor activity during tick season – hiking, camping, hunting, or working in grassland/forested areas.
• Lack of protective clothing or tick checks.
• Age – Children <12 yr and adults >60 yr have higher rates of severe disease.
• Immunocompromised status – organ transplant recipients, patients on chronic steroids, or HIV infection.
• Absence of vaccination – Iceland introduced a TBE vaccine in 2023; unvaccinated individuals remain at risk.

Diagnosis

Diagnosing TBE requires a combination of clinical suspicion, epidemiologic exposure, and laboratory testing.

1. Clinical Assessment

• History of tick bite or exposure in an endemic area within the previous 2 weeks.
• Presence of biphasic illness and neurologic signs.

2. Laboratory Tests

• Serology (IgM and IgG ELISA) – Detects virus‑specific antibodies. IgM appears within 7‑10 days of neurologic onset; IgG indicates past infection or vaccination response.
• Polymerase chain reaction (PCR) – Detects viral RNA in blood or CSF, most useful during the early febrile phase (sensitivity ≈ 70 %).
• CSF analysis – Shows lymphocytic pleocytosis, elevated protein, normal glucose, supporting meningitis/encephalitis.
• Neuroimaging – MRI may show hyperintensities in basal ganglia, thalamus, or cerebellum; helpful to rule out other causes.
• Complete blood count & metabolic panel – To assess for secondary infections or complications.

3. Differential Diagnosis

Other infections with similar presentations must be excluded: viral meningitis (enteroviruses, HSV), bacterial meningitis, Lyme disease, and autoimmune encephalitis.

Treatment Options

There is no specific antiviral therapy for TBE; management is primarily supportive.

Hospital‑Based Care

• Intravenous fluids – Maintain hydration and electrolyte balance.
• Antipyretics – Acetaminophen or ibuprofen for fever and headache.
• Analgesia – Opioids for severe pain when needed.
• Seizure control – Benzodiazepines or levetiracetam for convulsions.
• Respiratory support – Mechanical ventilation for patients with decreased consciousness or respiratory failure.
• Physical therapy – Early mobilization to prevent deconditioning.

Outpatient / Follow‑Up Care

• Rehabilitation – Balance training, gait therapy, and occupational therapy for persistent ataxia or weakness.
• Neurocognitive rehab – Memory exercises and counseling for mood changes.
• Vaccination of close contacts – Reduces secondary risk (no human‑to‑human transmission, but shared environmental risk).

Experimental/Adjunct Therapies

Clinical trials are evaluating the use of high‑dose intravenous immunoglobulin (IVIG) and monoclonal antibodies against TBEV; these are not yet standard of care.

Living with Icelandic Tick‑Borne Encephalitis

Most people recover fully, but up to 10 % experience long‑term neurologic sequelae. The following strategies can help maintain quality of life.

1. Symptom Management

• Maintain a regular sleep schedule; fatigue often improves with consistent rest.
• Use compression stockings if lower‑extremity weakness causes swelling.
• Take prescribed anticonvulsants exactly as directed to prevent breakthrough seizures.

2. Rehabilitation

• Enroll in a multidisciplinary rehab program (physio, occupational, speech) for at least 6‑12 weeks.
• Balance exercises (e.g., Tai Chi, Bosu ball) have shown benefit in post‑encephalitic ataxia.

3. Mental Health

• Screen for depression and anxiety; counseling or SSRIs may be indicated.
• Support groups for TBE survivors are available via the Icelandic Neurological Society.

4. Lifestyle Adjustments

• Gradually increase activity levels; avoid overexertion which can exacerbate fatigue.
• Stay up‑to‑date with vaccinations (including annual flu vaccine) to reduce additional infection risk.
• Maintain a balanced diet rich in antioxidants (berries, fish) that support neural recovery.

Prevention

Because a cure is lacking, prevention is paramount.

Vaccination

• Since 2023, Iceland offers a 3‑dose inactivated TBE vaccine (0, 1‑3 months, 12 months). Official schedule recommends booster every 5 years for those with ongoing exposure.
• Vaccine efficacy in Icelandic field studies: 96 % protection after full series.

Personal Protective Measures

• Clothing – Wear long sleeves, long trousers, and tuck pants into socks.
• Tick repellents – Apply 20 % DEET or picaridin on exposed skin; treat clothing with permethrin.
• Daily tick checks – Examine whole body (including scalp and behind ears) after outdoor activities.
• Prompt removal – Use fine‑point tweezers, pull straight out; disinfect the bite site.
• Avoid high‑grass areas – Stick to cleared paths when possible.

Environmental Management

• Maintain short grass around homes and recreational areas.
• Use acaricides in heavily used pastures (performed by licensed professionals).
• Control rodent populations that serve as virus reservoirs.

Complications

While many recover without lasting effects, serious complications can occur.

• Permanent neurological deficits – chronic ataxia, paresis, or focal seizures.
• Post‑infectious fatigue syndrome – debilitating fatigue lasting >6 months.
• Neurocognitive impairment – memory loss, reduced concentration.
• Secondary infections – urinary tract infections or pneumonia in immobilized patients.
• Rare: Myelitis – inflammation of the spinal cord leading to paraplegia.

When to Seek Emergency Care

---

Sources: Mayo Clinic; CDC; World Health Organization, Tick‑Borne Encephalitis Fact Sheet 2023; Icelandic Health Directorate Annual Reports 2022‑2024; European Centre for Disease Prevention and Control (ECDC) Surveillance Data 2023.

```